does the signature at mgm have a casino
Guwahati: A delegation from the All Bodo Students Union (ABSU), led by its president Dipen Boro, along with BTR Chief Executive Pramod Boro, MPs Rwngwra Narzary and Joyanta Basumatary, met Union Home Minister Amit Shah in New Delhi. The meeting focused on several key issues concerning the Bodo community and the implementation of the Bodo Territorial Region (BTR) Accord. Invitation to ABSU’s 57th Annual Session: The delegation extended a formal invitation to Amit Shah to attend the 57th ABSU session, scheduled to take place in Kokrajhar. Discussion on the BTR Accord: The progress and challenges in implementing the BTR Accord were discussed in detail. The leaders emphasized the need for expedited action on agreed commitments. Proposal to Honor Bodofa Upendranath Brahma: A proposal to name a road in New Delhi after Bodofa Upendranath Brahma, a revered leader of the Bodo community, was submitted. Demand for Constitutional Reforms: The ABSU demanded the enactment of the 125th Constitutional Amendment to strengthen provisions under the Sixth Schedule for Bodo-dominated areas. Infrastructure Development: The delegation urged the central government to expedite the ₹1,500 crore infrastructure development projects promised under the Bodo Accord. Recognition of Hill Bodos as Scheduled Tribes: The delegation called for recognizing Bodo communities living in the hills as Scheduled Tribes (Hills) to ensure their social and economic upliftment. Release of NDFB Cadres: The ABSU demanded the withdrawal of all cases against National Democratic Front of Boroland (NDFB) cadres and the release of those still imprisoned.
Lanier's huge first half propels No. 11 Tennessee to 77-62 win over No. 13 Baylor in the Bahamas
After Trump’s win, Black women are rethinking their role as America’s reliable political organizers‘None of these are radical’: Elisabeth Armitage delivers 35 recommendations following coronial inquest into DFSV deaths in the NTHigh Point defeats Pfeiffer 81-50
Ahmedabad: It has been four years since the National Education Policy 2020 was approved by the Union cabinet, yet state universities have failed to completely implement it. The policy's core focus on student credit transfer remains largely unrealized, particularly affecting students moving between universities within the state. At a recent meeting, state education department officials and vice chancellors of the state's public universities addressed crucial aspects, including credit transfer mechanisms, multiple entry-exit options and swift policy implementation. The department issued directives to develop a comprehensive roadmap within three months. This new education policy, introduced after a 34-year gap, stresses key aspects such as opportunities, accountability, inclusive education and excellence. Despite its launch, implementation issues persist across various public universities. During the meeting, officials stressed immediate policy execution, with vice chancellors being asked to achieve 50% gross enrolment ratio in higher education by 2035. The department will also hold quarterly review meetings to monitor progress in the implementation of NEP 2020. It also ordered VCs to set up objectives and submit detailed implementation strategies at the next quarterly meeting. The policy's provisions for multiple entry-exit points remain largely theoretical, with most universities failing to establish practical systems. Other issues include insufficient internship arrangements. Universities were told to adopt modern technologies, including AI, and move away from traditional practices. Sources said that govt data reveals that while 8 lakh Indian students pursue education abroad annually, India attracts only 45,000 international students. The policy addresses this imbalance by inviting the world's top 100 universities to set up campuses in India. The VCs of state universities were also instructed to create and upload Academic Credit Bank data to DigiLocker. Currently, only a few institutions like GTU and Gujarat University have completed this requirement. Additionally, plans were discussed to integrate all universities into a unified platform like the Gujarat Common Admission Service (GCAS). Sources said that despite biannual meetings between the education department and university authorities, NEP implementation has not progressed as expected. Sources said that universities merely provide data without actual policy implementation.
Fauda star Tsahi Halevi sings 'Tujhe Dekha Toh...' for Indian producer Rahul Mittra in Israel
Group of B.C. Conservative MLAs turn on fellow caucus member for backing police board member's resignationU.S. Rep. Kweisi Mfume said Friday that he won’t attend President-elect Donald Trump’s Jan. 20 inauguration because it falls on the holiday marking Martin Luther King Jr.’s birthday.Trump taps forceful ally of hard-line immigration policies to head Customs and Border Protection
CSIRO hails successful road test of lower-cost green hydrogen technology at steel plant - RenewEconomyNAFDAC has announced the withdrawal, suspension, and cancellation of several pharmaceutical products in Nigeria, prohibiting their manufacture, importation, sale, and use The affected products include Abacavir Sulfate/Lamivudine, Amaryl M, and Flagyl, among others, due to various reasons provided by their market authorization holders The agency urges the public to discontinue use and distribution of these products to ensure safety and compliance CHECK OUT: Learn at Your Own Pace! Our Flexible Online Course allows you to fit copywriting skills development around your busy schedule. Enroll Now! The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the withdrawal, suspension, and cancellation of approval for several pharmaceutical products. This decision, shared via a post on X, affects the manufacture, importation, exportation, distribution, advertisement, sale, and use of these products within Nigeria . List of Withdrawn Products Abacavir Sulfate/Lamivudine Dispersible Tablets 60mg/30mg Tablets – NAFDAC Number: C4-1180. Active Ingredient: Abacavir sulfate and Lamivudine. Market Authorization Holder: Healthline Limited. Amaryl M Tablets – NAFDAC Number: A4-2619. Active Ingredient: Glimepiride + Metformin Hydrochloride. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Amaryl M SR Tablets – NAFDAC Number: A4-7296. Active Ingredient: Glimepiride + Metformin Hydrochloride. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Aprovasc 150mg/5mg Tablets – NAFDAC Number: B4-2687. Active Ingredient: Amlodipine Besylate + Aprovasc. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Artemether/Lumefantrine 40mg/240mg Tablets – NAFDAC Number: B4-5745. Active Ingredient: Artemether/Lumefantrine 40mg/240mg. Market Authorization Holder: Healthline Limited. ASAQ (Artesunate Amodiaquine Winthrop) 100mg/270mg Tablets – NAFDAC Number: A4-3357. Active Ingredient: Artesunate Amodiaquine Winthrop 100mg/270mg. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. ASAQ (Artesunate Amodiaquine Winthrop) 25mg/67.5mg Tablets – NAFDAC Number: A4-3406. Active Ingredient: Artesunate Amodiaquine Winthrop 25mg/67.5mg. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. ASAQ (Artesunate Amodiaquine Winthrop) 50mg/135mg Tablets – NAFDAC Number: A4-3405. Active Ingredient: Artesunate Amodiaquine Winthrop 50mg/135mg. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Betopic Eye Drop – NAFDAC Number: 04 2404. Active Ingredient: Batexolol Hydrochloride. Market Authorization Holder: Novartis. Coaprovel 300mg/25mg Tablets – NAFDAC Number: B4-2317. Active Ingredient: Hydrochlorothiazide + Irbesartan. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Combination 3 Tablets – NAFDAC Number: A4-6459. Active Ingredient: Estrogen, Progestin. Market Authorization Holder: Bayer East Africa Limited. Efavirenz 600mg Tablets – NAFDAC Number: A4-1318. Active Ingredient: Efavirenz 600mg. Market Authorization Holder: Healthline Limited. Elisca Eye Drop – NAFDAC Number: 04 2461. Active Ingredient: Chloramphenicol Eye Drop. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Flagyl Suspension – NAFDAC Number : A4-3947. Active Ingredient: Metronidazole Benzoate. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Flagyl Tablet 400mg – NAFDAC Number: 04 5566. Active Ingredient: Metronidazole. Market Authorization Holder: Sanofi Aventis Nigeria Ltd. Iliadin Adult 0.05% Metered Nose Spray – NAFDAC Number: B4-9913. Active Ingredient: Oxymetazoline HCl 0.05%M/V. Market Authorization Holder: Fensyl MHP Consulting Ltd. Iliadin Baby 0.01% Nose Drops – NAFDAC Number: C4-0106. Active Ingredient: Oxymetazoline HCl 0.01%M/V. Market Authorization Holder: Fensyl MHP Consulting Ltd. Iliadin Kids 0.025% Nose Drops – NAFDAC Number: B4-9912. Active Ingredient: Oxymetazoline HCl 0.025%M/V. Market Authorization Holder: Fensyl MHP Consulting Ltd. Invanz 1g Injections – NAFDAC Number: 04 8118. Active Ingredient: Ertapenem 1g. Market Authorization Holder: MSD Idea Pharmaceuticals Nigeria Ltd. Invega (Paliperidone) 3mg Extended Release Tablets – NAFDAC Number: B4-8223. Active Ingredient: Paliperidone. Market Authorization Holder: Janssen Pharmaceutical Companies. Read also Tinubu names heads for Northwest, Southeast Development commissions, renominates others in new list PAY ATTENTION : Standing out in social media world? Easy! "Mastering Storytelling for Social Media" workshop by Legit.ng. Join Us Live! Advisory to the Public NAFDAC advises the public to discontinue the use, sale, and distribution of these products. The agency emphasizes the importance of ensuring that only approved and safe medications are available in the market to protect public health. NAFDAC Deregisters, Bans Popular Beauty Soap Meanwhile, Legit.ng earlier reported that the National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding the recall of Dove Beauty Cream Bar Soap (100g) with batch number 81832M 08. The product, manufactured in Germany, has been found to contain Butylphenyl Methylpropional (BMHCA), a chemical impurity that poses significant health risks. PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy! Source: Legit.ng
Victor Peskin: ICC arrest warrants for Netanyahu, Hamas leader doesn’t mean those accused will face trial anytime soon